# DarioHealth (DRIO) — Earnings

DRIO · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/drio/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | −$0.85 |
| EPS estimate | −$1.22 |
| EPS surprise | +30.04% |
| Revenue surprise | −12.56% |
| Revenue | $5.2M |
| Revenue estimate | $5.9M |
| Reported | Aug 11, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1533998/000110465926093645/drio-20260630x10q.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/0af84baf-0c6c-aa81-eeb0-6d54ab9888c5.html) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 11, 2026 | −$1.22 | −$0.85 | 30.04% | $5.9M | $5.2M |
| Q1 2026 | May 13, 2026 | −$1.48 | −$1.25 | 15.54% | $5.5M | $5.6M |
| Q4 2025 | Mar 19, 2026 | −$3.24 | −$2.27 | 30.07% | $5.0M | $5.2M |
| Q3 2025 | Nov 13, 2025 | −$4.90 | −$2.96 | 39.59% | $5.7M | $5.0M |
| Q2 2025 | Aug 12, 2025 | −$4.67 | −$3.60 | 22.86% | $6.9M | $5.4M |
| Q1 2025 | May 14, 2025 | −$2.00 | −$2.80 | -40.00% | $7.5M | $6.8M |
| Q4 2024 | Mar 10, 2025 | −$6.67 | −$1.60 | 76.00% | $7.4M | $7.6M |
| Q3 2024 | Nov 7, 2024 | −$4.33 | −$5.00 | -15.39% | $7.4M | $7.4M |
| Q2 2024 | Aug 8, 2024 | −$8.90 | −$1.60 | 82.02% | $7.9M | $6.3M |
| Q1 2024 | May 15, 2024 | −$5.90 | −$4.00 | 32.20% | $6.8M | $5.8M |
| Q4 2023 | Mar 28, 2024 | −$7.80 | −$8.20 | -5.13% | $3.8M | $3.6M |
| Q3 2023 | Nov 2, 2023 | −$10.40 | −$9.80 | 5.77% | $5.4M | $3.5M |
| Q2 2023 | Aug 10, 2023 | −$10.28 | −$11.60 | -12.84% | $6.5M | $6.2M |
| Q1 2023 | May 11, 2023 | −$9.96 | −$9.00 | 9.64% | $6.7M | $7.1M |
| Q4 2022 | Mar 9, 2023 | −$12.20 | −$8.40 | 31.15% | $6.7M | $6.8M |
| Q3 2022 | Nov 14, 2022 | −$15.26 | −$12.80 | 16.10% | $6.3M | $6.6M |
| Q2 2022 | Aug 15, 2022 | −$15.09 | −$14.80 | 1.89% | $8.3M | $6.2M |
| Q1 2022 | May 12, 2022 | −$19.14 | −$14.80 | 22.69% | $6.8M | $8.1M |
| Q4 2021 | Mar 22, 2022 | −$23.14 | −$23.80 | -2.84% | $6.0M | $6.0M |
| Q3 2021 | Nov 15, 2021 | −$19.74 | −$27.19 | -37.72% | $5.8M | $5.6M |

## Frequently Asked Questions

### When did DarioHealth (DRIO) last report earnings?

DarioHealth last reported on Aug 11, 2026, covering fiscal Q2 2026.

### Did DRIO beat earnings estimates?

Yes. DarioHealth reported EPS of −$0.85 for Q2 2026 against a −$1.22 estimate — a 30.04% beat.

### How much revenue did DRIO report last quarter?

DarioHealth reported $5.2M in revenue for Q2 2026, against a consensus estimate of $5.9M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).